Scilex Holding (SCLX) Other Operating Expenses (2020 - 2026)

Scilex Holding (SCLX) posted quarterly Other Operating Expenses of -$18.1 million for Q1 2026, down 7.0% on a QoQ basis from -$16.9 million in Q4 2025.

Scilex Holding (SCLX) Other Operating Expenses (2020 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Other Operating Expenses for 7 consecutive years, with -$18.1 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Other Operating Expenses changed N/A year-over-year to -$18.1 million; the TTM figure through Mar 2026 stood at -$25.9 million (down 579.86% YoY), while the FY2025 annual figure was -$12.2 million, changed N/A from the prior year.
  • Other Operating Expenses came in at -$18.1 million for Q1 2026 at Scilex Holding, down from -$16.9 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $5.5 million in Q4 2023, with the low at -$18.1 million in Q1 2026.
  • Average Other Operating Expenses over 5 years is $418558.1, with a median of $4.4 million recorded in 2023.
  • Across the five-year window, Other Operating Expenses jumped 4961.73% in 2022 and plunged 143.83% in 2024, its largest moves.
  • Year by year, Other Operating Expenses stood at $5.5 million in 2022, then gained by 0.14% to $5.5 million in 2023, then dropped by 2.81% to $5.4 million in 2024, then tumbled by 413.15% to -$16.9 million in 2025, then fell by 7.0% to -$18.1 million in 2026.
  • According to Business Quant data, Other Operating Expenses over the past three periods registered -$18.1 million, -$16.9 million, and $4.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -18.06 Mn
Dec 31, 2025 -16.88 Mn
Sep 30, 2025 4.70 Mn
Jun 30, 2025 4.38 Mn
Jun 30, 2024 5.39 Mn
Mar 31, 2024 -2.02 Mn
Dec 31, 2023 5.55 Mn
Sep 30, 2023 4.42 Mn
Jun 30, 2023 5.20 Mn
Mar 31, 2023 4.62 Mn
Dec 31, 2022 5.54 Mn
Sep 30, 2022 526,359.00
Jun 30, 2022 3.00 Mn
Mar 31, 2022 -485,807.00
Dec 31, 2021 1.52 Mn
Sep 30, 2021 -1.16 Mn
Jun 30, 2021 -61,609.00
Mar 31, 2021 1.49 Mn
Dec 31, 2020 6,276.00
Sep 30, 2020 856.00